Ads
related to: outlook
Search results
MongoDB Earnings: Slashing Valuation as Execution and Macro to Blame for Lower Guidance
Morningstar· 37 minutes agoDespite beating expectations on Q1 earnings, the outlook sours. No-moat MongoDB’s first-quarter...
Indexes Mixed After Inflation Fears Fall; Nvidia Eyes Apple's Crown
Investor's Business Daily· 51 minutes agoShares are recovering a bit from an earnings sell-off on Thursday. Health stocks fared well in the...
AM Best Revises Outlooks to Stable, Affirms Excellent Ratings for MEMIC Group
Insurance Journal· 6 hours agoAM Best has revised the outlooks to stable from negative and affirmed the Financial Strength Rating...
Burlington Stores stock target raised on strong earnings By Investing.com
Investing.com· 3 hours agoOn Friday, BMO (TSX:BMO) Capital Markets adjusted its outlook on Burlington Stores (NYSE:BURL),...
John Lennon’s son Sean blasts ‘idiot’ Prince Harry’s ‘Spare’ memoir in belated review
Page Six· 1 hour ago“I do [empathize with him],” the musician, 48, tweeted. “[That’s] why I’m very disappointed with his...
Invest in SpaceX Alongside Elon Musk? Why This Closed-End Fund Is Not Worth the Ride
Morningstar· 1 hour agoNvidia’s stock split is coming soon. What Morningstar thinks of the chipmaker’s value and outlook as...
Birkenstock share target raised, retains Buy on currency-neutral revenue growth By Investing.com
Investing.com· 3 hours agoStifel has updated its financial outlook on Birkenstock Holding plc (NYSE: NYSE:BIRK), raising the...
Live Nation outlook lowered by S&P Global amid Justice Department antitrust lawsuit
Yahoo Finance· 1 day agoS&P Global downgraded its outlook for Live Nation Entertainment (LYV) to negative on Thursday,...
IG Group shares target raised by RBC on improved outlook By Investing.com
Investing.com· 11 hours agoOn Friday, RBC (TSX:RY) Capital updated its outlook on IG Group Holdings (IGG:LN) (OTC: IGGHY)...
Ultragenyx shares target raised, keeps Buy rating on successful outcome By Investing.com
Investing.com· 2 hours agoOn Friday, Canaccord Genuity adjusted its outlook on Ultragenyx Pharmaceutical (NASDAQ:RARE) Inc....